Literature DB >> 12583843

Treatment approaches for children with Tourette's syndrome.

Bennett L Lavenstein1.   

Abstract

Tourette's syndrome has been of neurologic and psychiatric interest since the original description of this condition by Gilles de la Tourette in 1885, and it has been associated with a wide variety of treatments over the years. With the advent of advances in neurochemistry and neuropharmacology, a neurobiologic approach has emerged with the application of many drugs from the fields of neurology and psychiatry. In addition, many of the comorbid conditions that coexist, such as attention deficit disorder and obsessive compulsive disorder (OCD), are amenable to both pharmacologic and behavioral approaches. Drug treatment has included dopamine receptor blockers for tics, dopamine agonists, dopamine depletors, and stimulants for attention deficit hyperactivity disorder (ADHD), noradrenergic drugs for tics and ADHD, serotonergic drugs for OCD, and chemical denervation for involuntary movements with the use of botulinum toxin and stereotactic surgery. It is the purpose of this review to outline the various approaches that are currently available as treatments, realizing that as new drugs are introduced in neurology and psychiatry, they too will find their way into treatment options.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12583843     DOI: 10.1007/s11910-003-0066-1

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  26 in total

Review 1.  Dopamine receptors--physiological understanding to therapeutic intervention potential.

Authors:  G Emilien; J M Maloteaux; M Geurts; K Hoogenberg; S Cragg
Journal:  Pharmacol Ther       Date:  1999-11       Impact factor: 12.310

2.  Stereotactic treatment of Gilles de la Tourette syndrome by high frequency stimulation of thalamus.

Authors:  V Vandewalle; C van der Linden; H J Groenewegen; J Caemaert
Journal:  Lancet       Date:  1999-02-27       Impact factor: 79.321

Review 3.  Tourette syndrome: pieces of the puzzle.

Authors:  J F Leckman; D J Cohen; C G Goetz; J Jankovic
Journal:  Adv Neurol       Date:  2001

4.  An open-label study of the treatment efficacy of olanzapine for Tourette's disorder.

Authors:  C L Budman; A Gayer; M Lesser; Q Shi; R D Bruun
Journal:  J Clin Psychiatry       Date:  2001-04       Impact factor: 4.384

5.  Botulinum toxin for simple motor tics: a randomized, double-blind, controlled clinical trial.

Authors:  C Marras; D Andrews; E Sime; A E Lang
Journal:  Neurology       Date:  2001-03-13       Impact factor: 9.910

6.  Transdermal nicotine and haloperidol in Tourette's disorder: a double-blind placebo-controlled study.

Authors:  A A Silver; R D Shytle; M K Philipp; B J Wilkinson; B McConville; P R Sanberg
Journal:  J Clin Psychiatry       Date:  2001-09       Impact factor: 4.384

7.  Long-term methylphenidate therapy in children with comorbid attention-deficit hyperactivity disorder and chronic multiple tic disorder.

Authors:  K D Gadow; J Sverd; J Sprafkin; E E Nolan; S Grossman
Journal:  Arch Gen Psychiatry       Date:  1999-04

8.  Relative efficacy of haloperidol and pimozide in children and adolescents with Tourette's disorder.

Authors:  F R Sallee; L Nesbitt; C Jackson; L Sine; G Sethuraman
Journal:  Am J Psychiatry       Date:  1997-08       Impact factor: 18.112

9.  Botulinum toxin injection into vocal cord in the treatment of malignant coprolalia associated with Tourette's syndrome.

Authors:  B L Scott; J Jankovic; D T Donovan
Journal:  Mov Disord       Date:  1996-07       Impact factor: 10.338

10.  Risperidone as a treatment for Tourette's syndrome.

Authors:  R D Bruun; C L Budman
Journal:  J Clin Psychiatry       Date:  1996-01       Impact factor: 4.384

View more
  4 in total

1.  Bridging neuroscience and clinical psychology: cognitive behavioral and psychophysiological models in the evaluation and treatment of Gilles de la Tourette syndrome.

Authors:  Marc E Lavoie; Julie Leclerc; Kieron P O'Connor
Journal:  Neuropsychiatry (London)       Date:  2013-02-01

2.  Toward a Multifactorial Conception of the Gilles de la Tourette Syndrome and Persistent Chronic Tic Disorder.

Authors:  Marc E Lavoie; Kieron O'Connor
Journal:  Brain Sci       Date:  2017-06-02

3.  Neurosurgical strategies for Gilles de la Tourette's syndrome.

Authors:  Karim Mukhida; Matthew Bishop; Murray Hong; Ivar Mendez
Journal:  Neuropsychiatr Dis Treat       Date:  2008-12       Impact factor: 2.570

Review 4.  Candidate Genes and Pathways Associated with Gilles de la Tourette Syndrome-Where Are We?

Authors:  Amanda M Levy; Peristera Paschou; Zeynep Tümer
Journal:  Genes (Basel)       Date:  2021-08-26       Impact factor: 4.096

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.